NCBiotech News

Orion Integrated Biosciences, a Kansas-based biodefense company with a growing presence in North Carolina, plans to use artificial intelligence to design vaccines to fight COVID-19.

If you’ve been diagnosed with the COVID-19 coronavirus and have recovered, you can help researchers find a potential treatment for the disease by donating at one of Grifols' plasma collection sites.

Grifols is collecting a blood product from recovered COVID-19 patients to develop a possible treatment for the coronavirus disease.

A new North Carolina medical software company, Translational Imaging Innovations, is developing tools to help scientists and doctors get medical innovations into the eye clinic faster, with less frustration and at a lower cost.

RedHill Biopharma has received approval to test its investigational COVID-19 drug, opaganib, in the United States.

The Asheville Impact Micro Grant, a Venture Asheville program, will award $5,000 to five new startups in Haywood or Buncombe County this year.

UNC is the highest-ranked U.S. university for coronavirus research, according to Microsoft Academic, a public search engine for scholarly publications, journals and other literature.

Two of the seven Alexandria LaunchLab $100,000 AgTech Innovation Prize finalists, TreeCo and TerMir, are based in the Triangle.

Researchers at UNCG are developing a unique new weapon to combat one of the major causes of honeybee declines: the parasitic mite called the Varroa destructor and the numerous viruses and other harmful pathogens it transmits.

Durham-based Chimerix has gotten the green light from the FDA to test an investigational cancer drug to treat COVID-19 patients.

NCBiotech awarded 13 grants and loans totaling $1.8 million to universities and bioscience companies in the third quarter of its current fiscal year.

Four North Carolina universities have teamed up to win a $5.7 million federal grant for diabetes research.

CED's Venture Connect Online starts today and runs for the next three weeks, giving over 90 growth-stage companies exposure to potential investors from around the world.

People who have recovered from COVID-19 may donate potentially lifesaving plasma at UNC, and Grifols is also collecting it at plasma donor sites elsewhere around the country.

Banner Life Sciences, a High Point pharmaceutical company, has gained final regulatory approval of a drug for treating multiple sclerosis.